MET and cancer: EVs isolated from cancer patients’ body fluids have been shown to contain cancer-derived molecules such as truncated EGFRvIII [52], overexpressed MET [53], cancer-specific miRNAs and protein signatures and mutated DNA or mRNA fragments [23, 54–56].